Overview

Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy

Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine ANB020 safety, tolerability and activity in adult patients with peanut allergy.
Phase:
Phase 2
Details
Lead Sponsor:
AnaptysBio, Inc.